NDA 071251 describes TRIAMTERENE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by
Ani Pharms,
Cadila,
Chartwell Rx,
Duramed Pharms Barr,
Lannett Co Inc,
Mylan,
Novartis,
Sandoz,
Vitarine,
Am Therap,
Apotex Inc,
Pliva,
Quantum Pharmics,
Rubicon,
Watson Labs, and
Zydus Pharms, and is included in twenty-two NDAs. It is available from
twenty-nine suppliers. Additional details are available on the
TRIAMTERENE AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is
hydrochlorothiazide; triamterene. There are thirty-two
drug master file entries for this compound. Twenty-nine
suppliers are listed for this compound. Additional details are available on the
hydrochlorothiazide; triamterene profile page.